Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katie E. Long"'
Autor:
Linda R. Bressler, Katie E. Long, J. Lee Villano, Nathalie Letarte, Michael Gabay, Joan M. Stachnik
Publikováno v:
Journal of Neuro-Oncology. 120:111-115
The EORTC-NCIC regimen for glioblastoma requires different dosing of temozolomide (TMZ) during radiation and maintenance therapy. This complexity is exacerbated by the availability of multiple TMZ capsule strengths. TMZ is an alkylating agent and the
Autor:
Joan M. Stachnik, Colleen L. Overley, Michael Gabay, Katie E. Long, Linda R. Bressler, John L. Villano, Scott Wirth
Publikováno v:
CNS drugs. 29(11)
The purpose of our review is to summarize the clinical activity of oral targeted agents against brain metastases. This includes BRAF inhibitors (dabrafenib and vemurafenib), human epidermal growth factor receptor inhibitors (lapatinib, gefitinib, erl
Publikováno v:
Journal of Clinical Oncology. 33:549-549
549 Background: Fatigue and anorexia are major side effects in the use of regorafenib. These effects are compounded in patients with metastatic colon cancer to the liver. Finding a good fit for this agent has been difficult in patients when used in t
Autor:
Jeremiah T. Martin, Ching Wei D. Tzeng, Mahesh Kudrimoti, Philip A. DeSimone, Peter J. Hosein, Colleen Overly, Ronald C. McGarry, Katie E Long, Lowell Anthony, Neha Ray
Publikováno v:
Journal of Clinical Oncology. 33:197-197
197 Background: Toxicities of the active triple-drug DCF regimen (docetaxel, cisplatin and 5-FU) in gastric cancer limit its broad use and general acceptance as first-line therapy. To improve the toxicity profile of triple-drug therapy, distal esopha
Publikováno v:
Journal of Clinical Oncology. 32:2100-2100
2100 Background: We evaluated the American College of Surgeon’s National Cancer Data Base (NCDB) to describe current hospital-based epidemiologic frequency and survival patterns of pediatric medull...